111In-ABT-806

N/A

Report date: 2025/10/20 14:38:45

NME

Base Information

Drug Name111In-ABT-806

Drug Alias NameABT-806i111In-ABT-806

ClassificationRadiation-emitting products > Nuclides > Indium > 111InRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionAnti-Epidermal growth factor receptor erbB1

TargetsEpidermal growth factor receptor erbB1

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAbbvie Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAbbvie Inc

Active IndicationsN/A

Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A